Catalyst Wire Dossier Catalyst Wire Dossier

PTX-35

PTX-35 · Pelican Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PTX-35, covering 2024-03-12 to 2024-03-12. Get the full timeline:

Most recent: Clinical Trial Update: PTX-35 in Patients With Advanced Solid Tumors [Phase 1]

See pricing